Sertraline in the Treatment of Depression Associated with Gonadotropin-Releasing Hormone Agonist Therapy

article OA: closed CC0 ⤵ 9 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
AI-generated summary by claude@2026-06, 2026-06-07

This study investigated the efficacy of sertraline in treating depression in patients undergoing gonadotropin-releasing hormone agonist therapy for prostate cancer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

1-Naphthylamine Antidepressive Agents, Second-Generation Antineoplastic Agents, Hormonal Depression Depression Endometriosis Gonadotropin-Releasing Hormone Leuprolide 1-Naphthylamine 1-Naphthylamine Adult Affect Antidepressive Agents, Second-Generation Antineoplastic Agents, Hormonal Antineoplastic Agents, Hormonal Depression Endometriosis Endometriosis Endometriosis Female

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (9)

Cited by (9)

Source provenance

europepmc
last seen: 2026-06-20T06:14:18.781669+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:10:40.754221+00:00
License: CC0 · commercial use OK